entertainment -WSS

entertainment

author：Wikipedia 2025-09-29 07:25:23 - browse：66

Biogen, a biotech giant plagued by years of boardroom strife, said late Monday that the longtime and polarizing director Alex Denner would step down from its board, sending a signal to investors that the company’s fractious recent history might be coming to a close.

What Biogen didn’t disclose is that its nominee to replace Denner on the board, Susan Langer, is Denner’s live-in romantic partner and the mother of his child, born in November, according to court records obtained by STAT. Denner is in the middle of a protracted divorce from his wife of nearly 25 years, with whom he has two teenage sons — a bitter legal fight in which his extramarital relationship with Langer is a contentious issue, according to the records.

Biogen spokesperson Jack Cox said the company knew about the relationship between Denner and Langer. He also said that Denner recommended Langer to Biogen’s board — he said he incorrectly stated at first that Denner nominated her — but declined to comment on the company’s vetting process and whether it planned to disclose the relationship to shareholders before they vote on Langer’s candidacy later this month. Biogen also omitted mention of the relationship from Langer’s biography in a Securities and Exchange Commission filing Tuesday morning.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Drug firms test therapies to halt Alzheimer’s before symptoms arise

knowledge

WSS

How to make AI work for medicine

Akili changes sales model for its ADHD video game treatment

Transgender sports debate: Physicians say bans are health issue

Complete sequence of Y chromosome published for first time

How a symptom of dementia informs our understanding of creativity

Why the drug industry's warnings on the IRA's impact fall short

hotspot

entertainment

hotspot

Medical records are filled with copy

Information blocking fines are now fair game in health care

Hepatitis C has a cure — but many Americans still lack access to it

Radiation, mainstay of cancer treatment, begins a fade

Dobbs anniversary: the lost opportunity of abortion as health care

Australia’s approach to dialysis celebrates life

BioMarin wins approval for gene therapy to treat hemophilia A

How Long Island became the ‘eugenics capital of the world’

Moonlake's readout produced a cash windfall. Risks remain

Midwives could help bridge maternal health disparities in the U.S.

hotspot

Assistant physicians can help address the primary care shortage

FDA panel to weigh safety of artificial wombs for preterm births

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Departing Stanford president retracts two papers

Eli Lilly CEO gives to Mike Pence presidential super PAC

How the messy conversation about Dolly changed bioethics

focus

knowledge

knowledge

focus